Browse studies, page 126

Page 126 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• A Randomized, Double-blind, Placebo-Controlled, Cross-Over Trial to Investigate the Effect of GSK189075 on Cardiac Repolarization as Compared to Placebo and a Single Dose of Moxifloxacin in Healthy Adult Subjects ClinicalTrials.gov · COMPLETED, 2008
• The Effect of Pink Grapefruit Juice on the QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome ClinicalTrials.gov · COMPLETED, 2019
• Randomized, Double-Blind, Double-Dummy, Placebo- and Positive Controlled, 4-Way Crossover Study to Assess the Effect of Single-Dose ACP-196 on the QTc Interval in Healthy Adult Subjects ClinicalTrials.gov · COMPLETED, 2016
• A Phase 1, Single-dose, Randomized, 4-treatment, 4-period Crossover, Placebo- And Positive-controlled, Double-blind (Open-label For Positive Control), Sponsor-open Study To Determine The Effect Of PF-04447943 On Qtc Interval In Healthy Adult Subjects ClinicalTrials.gov · COMPLETED, 2016
• A Single-centre, Double-blind, Double-dummy, Randomised, Placebo-controlled, Four-period Crossover Study to Assess the Effect of Single Oral Doses of AZD5672 (600 mg and 150 mg) on QT/QTc Interval, Compared to Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers ClinicalTrials.gov · COMPLETED, 2009
• Thorough QT Study to Evaluate the Effects of BI 409306 as Single Dose on Cardiac Safety Parameters in Healthy Male and Female Subjects. A Randomized, Placebo Controlled, Double-blind, Five-period Crossover Study With (Open-label) Moxifloxacin as Positive Control ClinicalTrials.gov · COMPLETED, 2019
• Effects of moxifloxacin and gemifloxacin on blood glucose level of euglycemics:a PRE-clinical and clinical study ClinicalTrials.gov · COMPLETED, 2021
• A Randomized, Placebo-Controlled Study to Evaluate the Effect of Tafenoquine (SB252263) on the Electrocardiogram (ECG) With Focus on Cardiac Repolarization (QTc Duration) in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2012
• Double-blind, Randomized, Placebo- and Positive-controlled, Parallel-group Trial to Assess the Potential Electrocardiographic Effects of Rotigotine Transdermal System up to 120 cm2/54.0 mg/Day in Subjects With Advanced-stage Idiopathic Parkinson's Disease: A Thorough QT/QTc Trial ClinicalTrials.gov · COMPLETED, 2006
• A Multiple-center, Multiple-dose, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Parallel Group Study to Investigate the Effect of RO4917838 on the QTc Interval in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2009
• Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification ClinicalTrials.gov · COMPLETED, 2013
• Clinical Evaluation of Systemic Moxifloxacin Compared to Amoxicillin Plus Metronidazole Adjunct to Non-surgical Treatment in Generalized Aggressive Periodontitis: A Randomized Clinical Trial ClinicalTrials.gov · COMPLETED, 2014
• A Phase I Single Centre, Randomized, Double Blind (Except For Moxifloxacin), Placebo And Active Controlled, Four Way Cross Over Study Investigating The Effect Of Single Therapeutic And Supra Therapeutic Doses Of Fedovapagon On The QT/QTC Interval In Healthy Volunteers Using Oral Moxifloxacin To Confirm Assay Sensitivity ClinicalTrials.gov · COMPLETED, 2015
• Assessment of the Effect of 25 mg and 200 mg of BI 10773 as Single Dose on the QT Interval in Healthy Female and Male Subjects. A Randomised, Placebo Controlled, Double-blind, Five-period Crossover Phase-I-study With Moxifloxacin as Positive Control ClinicalTrials.gov · COMPLETED
• A Phase I, Multicenter, Randomized, Double-blind, Double-dummy, Placebo- and Positive-Controlled Study to Investigate the Effects of CBP-307 on the QTc Interval in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2022
• Effect of BMS-650032 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate (Ortho Tri- Cyclen (R)) in Healthy Female Subjects ClinicalTrials.gov · COMPLETED, 2010
• An Open Label Study to Evaluate Cycle Control With Ortho Tri-Cyclen Lo (Norgestimate/Ethinyl Estradiol) and Yaz (Drospirenone/Ethinyl Estradiol) in Healthy Sexually Active Females ClinicalTrials.gov · COMPLETED, 2008
• Antibiotic Prophylaxis for ERCP: a Comparison of Intravenous Ceftriaxone With Intravenous Moxifloxacin in the Prophylaxis of Cholangitis ClinicalTrials.gov · COMPLETED, 2015
• A Phase 1, Single-Dose, Randomized, Placebo- and Positive-Control, Four-Way, Crossover Study for the Evaluation of the Effect of Epetraborole on QT Intervals in Healthy Adult Subjects ClinicalTrials.gov · COMPLETED, 2023
• A Four Period, Four-Arm, Crossover Design, Randomized, Placebo and Active Controlled Study for the Evaluation of the Effect of Therapeutic and Supratherapeutic Single-Dose ANX-188 on the QT/QTc Intervals in Healthy Volunteers ClinicalTrials.gov · COMPLETED, 2013
• Prospective, Multicenter, Open, Uncontrolled Trial to Evaluate the Time to Bacterial Eradication and Key Symptom Relief in the Treatment of Acute Bacterial Maxillary Sinusitis With Moxifloxacin 400 mg QD ClinicalTrials.gov · COMPLETED, 2005
• A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Positive-Controlled, Four-Way Crossover Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2022
• A Phase I, Randomized, Gender Stratified, Double-Blind, Placebo- and Positive-Controlled, Three Period Crossover Trial to Assess the Effect of Guanfacine Hydrochloride on QT/QTc Interval in Healthy Men and Women ClinicalTrials.gov · COMPLETED, 2008
• Phase I, Randomized, Parallel Group Study to Evaluate the Effect of Multiple Oral Doses of Eurartesim on the QT/QTc Interval Compared to Riamet, Placebo and Moxifloxacin in Healthy Male and Female Volunteers ClinicalTrials.gov · COMPLETED, 2010
• Dropless Pars Plana Vitrectomy Study ClinicalTrials.gov · COMPLETED, 2026
• Phase IV Study; Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation ClinicalTrials.gov · COMPLETED, 2010
• Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349 ClinicalTrials.gov · COMPLETED, 2021
• Cerebral Manifestation of Miliary Tuberculosis Mimicking a Parasitic CNS Infection Case reports in neurological medicine, 2026
• Proteomic Insights Into Moxifloxacin Efficacy and Resistance in Vibrio parahaemolyticus Proteomics, 2026
• A viral uveitis masquerade: PCR-confirmed Listeria monocytogenes necrotizing chorioretinitis complicated by secondary macular hole Journal of ophthalmic inflammation and infection, 2026
• An ingestible origami-inspired metamaterial for prolonged oral delivery of therapeutics Nature communications, 2026
• Fluoroquinolone-induced liver injury and pharmacists' interventions in pneumonia: a case report and clinical pharmacist intervention Current drug safety, 2026
• Nummular Keratitis Following Epidemic Keratoconjunctivitis: A Guide to Managing Subepithelial Infiltrates Cureus, 2026
• Acute Unilateral Iris Transillumination Following Topical Moxifloxacin: A Case Report and Anterior Segment Optical Coherence Tomography Findings Ocular immunology and inflammation, 2026
• In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA) bioRxiv, 2026
• Comparative whole genome analysis of Mycobacterium tuberculosis isolated from BPaLM and individualized regimen treated patients at Dr. Soetomo Hospital, Indonesia Molecular biology reports, 2026
• Clofazimine pharmacokinetics in novel rifampicin-resistant tuberculosis regimens: an analysis of the endTB and endTB-Q trials 2026
• Beyond Rifampin: Evaluating Rifapentine and Rifabutin as Alternative Treatments for Tuberculous Meningitis The Journal of infectious diseases, 2026
• Synergy between orally bioavailable antibiotics and dalbavancin against MRSA The Journal of antimicrobial chemotherapy, 2026
• Decoding moxifloxacin resistance in pre-XDR tuberculosis using MGIT 960 and MYCOTB AST. Indian journal of medical microbiology, 2026
• 2H-Chromen-2-one Disrupts the Staphylococcus aureus Biofilm Matrix and Potentiates Moxifloxacin Activity: In Vitro and In Silico Analyses Microbial pathogenesis, 2026
• Implementing a Program of Comprehensive Tuberculosis Preventive Treatment: Safety, Effectiveness, and Acceptability of Moxifloxacin or Bedaquiline Use for Contacts Exposed to Drug-Resistant Strains Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026
• Recalcitrant infectious crystalline keratopathy caused by Acanthamoeba and Fusarium coinfection Ocular immunology and inflammation, 2026
• Adaptive Laboratory Evolution under gradual ciprofloxacin stress leads to efflux-mediated ciprofloxacin resistance and an increase in endogenous antibiotic production in Streptomyces coelicolor 2026
• Treatment of multidrug-resistant tuberculosis with bedaquiline, pretomanid, linezolid, and moxifloxacin following near-total gastrectomy ASM case reports, 2026
• Nonclinical pharmacokinetics and relative efficacy of the first 25 novel tuberculosis drug combinations from the PAN-TB consortium: Use of the BALB/c relapsing mouse model and combination pharmacokinetics within a modeling-based framework 2026
• Ciprofloxacin-Induced Oxidative Stress Promotes a Senescence-like Phenotype in Human Fibroblasts In Vitro International journal of molecular sciences, 2026
• Toward optimal moxifloxacin dosing in tuberculous meningitis: A translational physiologically based pharmacokinetic modeling approach medRxiv, 2025
• MIC-based tuberculosis drug susceptibility testing using Sensititre MYCOTB: a diagnostic accuracy meta-analysis Journal of clinical microbiology, 2026
• Fluoroquinolones boron complexes as promising antibiotics and fluorescent probes: single crystal, photophysical, theoretical and antimicrobial studies Bioorganic chemistry, 2026
• Failure of Endophthalmitis Prophylaxis: A Laboratory Model Comparing Antibiotics and Bacterial Loads Journal of cataract and refractive surgery, 2026
• Acute bacterial endophthalmitis with focal vitritis at a nasal chandelier illumination port after scleral buckling IDCases, 2026
• Distribution of ABCB1 Genetic Variants and their Association with Moxifloxacin Pharmacokinetics in Hospitalized Patients with Acute Exacerbation of COPD Balkan journal of medical genetics : BJMG, 2026
• Role of Adjunctive Intravitreal Therapy in Intraocular Tubercular Granuloma at a Tertiary Uveitis Care Centre - A Retrospective Case Series Ocular immunology and inflammation, 2026
• Endogenous Klebsiella pneumoniae Endophthalmitis With Iris Abscess and Discordant Systemic and Ocular Culture Susceptibilities Journal of vitreoretinal diseases, 2026
• Declining Fluoroquinolone Efficacy in Resistance-Guided Therapy for Mycoplasma genitalium: A Systematic Review and Meta-Analysis of Microbiological Cure Sexually transmitted diseases, 2026
• Clinical characteristics of Chlamydia psittaci pneumonia diagnosed by next-generation sequencing: An observational study Medicine, 2026
• Non-Tuberculous Mycobacterium Peritoneal Dialysis-Associated Peritonitis: A Case Report of Mycobacterium neoaurum Canadian journal of kidney health and disease, 2026
• Detection and antimicrobial susceptibility of genital mycoplasmas in women and men, with 23S rRNA and parC mutation analysis in Mycoplasma genitalium Scientific reports, 2026
• Bioorthogonal Polymer Nanozymes for Effective Treatment of Bacterial Wound Biofilm Infections ACS applied materials & interfaces, 2026
• Experimental Study on Anti-Infection and Promotion of Macrophage Polarization for the Treatment of Traumatic Bone Infection Using Rifampicin/Moxifloxacin-Loaded PLGA Microspheres Frontiers in bioscience (Landmark edition), 2026
• Efficacy of Mid-Procedure Lidocaine in Reducing Pain from Intracameral Moxifloxacin Injection During Cataract Surgery 2026
• pH-Dependent Evolution of Delafloxacin and Ciprofloxacin Resistance in Pseudomonas aeruginosa from cystic fibrosis (CF) and non-CF-patients 2026
• Dropless Pars Plana Vitrectomy Using Intravitreal Decanted Triamcinolone and Moxifloxacin: Safety and Efficacy Retina (Philadelphia, Pa.), 2026
• Endophthalmitis prevention in Refractive Lens Exchange Archivos de la Sociedad Espanola de Oftalmologia, 2026
• Biocompatibility and antibacterial properties of ordered PLA fiber membranes fabricated via electrospinning technology iScience, 2026
• Coordinated topoisomerase function shapes the fluoroquinolone response of Chlamydia trachomatis Microbiology spectrum, 2026
• Pleural effusion caused by Rickettsia felis infection Journal of infection in developing countries, 2026
• Generalized Hailey-Hailey Disease Complicated by MRSA Infection: A Case Report of Management with Systemic Corticosteroids and Targeted Anti-Infective Therapy Clinical, cosmetic and investigational dermatology, 2026
• The Effect of Carbetocin on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled QT/QTc Study in Healthy Adults Clinical and translational science, 2026
• Next Generation TB Drug Combinations from the Pan-TB Consortium: Combination Efficacy and Contributions of Individual Agents, Evaluated in a BALB/c Mouse TB Model 2026
• Density functional theory‑elucidated α-ZrP/phosphorus-nitrogen co-doped hollow carbon spheres composite for highly sensitive electrochemical detection of moxifloxacin Mikrochimica acta, 2026
• Clinical Characteristics, Susceptibility Profiles, and Treatment of Rapidly Growing Mycobacteria in a Tertiary General Hospital in China 2026
• Moxifloxacin-induced insomnia with psychotic episodes in a toddler: a case report European journal of hospital pharmacy : science and practice, 2026
• Real-world treatment outcomes and adverse events during BPaLM therapy for rifampicin-resistant TB IJTLD open, 2026
• Potential limited cross-drug reaction among fluoroquinolones: A large database analysis by International Classification of Diseases, Tenth Revision code-based approach The journal of allergy and clinical immunology. Global, 2026
• Endphthalmitis after cataract surgery in Sweden 2018-2024: associations with preoperative visual acuity and intracameral antibiotic regimens The British journal of ophthalmology, 2026
• Clinical Features of 19 Cases of Psittacosis Pneumonia in Hangzhou, Southern China Research Square, 2026
• Declining Efficacy of Moxifloxacin for Mycoplasma genitalium Infection: Time for Fluoroquinolone Resistance-Guided Therapy? The Journal of infectious diseases, 2026
• Toxic Posterior Segment Syndrome Following Dropless Cataract Surgery With Compounded Triamcinolone-Moxifloxacin Ophthalmic surgery, lasers & imaging retina, 2026
• Antibiotic resistance mutations in Mycoplasma genitalium and non-gonococcal urethritis treatment outcomes Sexually transmitted diseases, 2026
• Mechanistic Insights into Moxifloxacin HCl Permeability from Nitrocellulose-Based In Situ Gels via Confocal Imaging and DFT Modeling AAPS PharmSciTech, 2026
• Evaluation of Direct susceptibility testing method for Moxifloxacin against Mycobacterium tuberculosis using the BACTEC MGIT 960 system medRxiv, 2026
• Adjunctive intravitreal moxifloxacin and ranibizumab in the management of intraocular tuberculoma. Retinal cases & brief reports, 2026
• Deep sequencing reveals subpopulation dynamics associated with treatment failure in a rare non-tuberculous mycobacterial infection 2026
• A randomized clinical trial to compare moxiFloxAcin veRsus aziTHromycin for the trEatment of MycoplaSma geniTalium: the FARTHEST Study Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026
• Species Identification and Antimicrobial Susceptibility of Mycobacterial Isolates from Dogs and Cats 2026
• Phagosomal acidification coordinates a lipid–redox program underlying antibiotic tolerance in Mycobacterium tuberculosis Research Square, 2026
• Why did fever persist after metagenomic next-generation sequencing confirmed Coxiella burnetii infection? A hidden co-infection beneath a single “positive” report 2026
• Outcomes of Microsporidial Keratoconjunctivitis Management During a Seasonal Outbreak at a Tertiary Eye Hospital 2026
• Moxifloxacin-Induced Bullous Acute Generalized Exanthematous Pustulosis (AGEP): A Case Report of a Rare Clinical Presentation Case reports in dermatological medicine, 2026
• Omadacycline vs. Moxifloxacin for Community-Acquired Pneumonia: A Real-World Retrospective Comparative Effectiveness and Safety Study Research Square, 2026
• Moxifloxacin-induced Abducens Nerve Palsy: A Rare Neurological Complication During Mycobacterium avium Complex Lung Disease Treatment Open respiratory archives, 2026
• Application of an Open-Source Modular Framework for Pharmacokinetic, Pharmacodynamic, and Safety Simulations to Anti-Tuberculosis Drugs CPT: pharmacometrics & systems pharmacology, 2026
• Acute effects of direct exposure to moxifloxacin on the porcine corneal endothelium: An ex vivo study Research in veterinary science, 2026
• Integrative Multi-Omics Analysis Suggests a Proteostasis-Translation-Neuroimmune Axis Underlying Moxifloxacin Associated Cognitive Impairment Molecular neurobiology, 2026
• Immune checkpoint blockade reshapes drug-associated toxicity: a pharmacovigilance atlas of drug-ICI interactions 2026
• Resveratrol attenuates moxifloxacin-induced oxidative damage in the liver, kidneys, brain, and serum of Wistar rats The Journal of international medical research, 2026
• MTB-LysB1:A Novel Endolysin Against Multidrug-Resistant Mycobacterium tuberculosis 2026
• Lung Adenocarcinoma Presenting With a Reduced Solid Component but Increased Overall Nodule Size After Antibiotic Therapy: A Case Report 2026